Christopher Cabell serves as Executive at ARENA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Christopher Cabell has executed 7 insider transactions totaling $884.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 21, 2026 involved selling 338,282 shares valued at $0.
Christopher Cabell currently holds 676,564 shares of ARENA PHARMACEUTICALS INC (ARNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Cabell has been a net seller of ARNA stock. They have purchased $0 and sold $884.0K worth of shares.
Christopher Cabell's most recent insider trade was on Feb 21, 2026, when they sold 338,282 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 18, 2023 | ZURA | $0 | Award | 162,060 | $N/A | Discretionary |
| Nov 25, 2020 | ARNA | $0 | Option Exercise | 2,500 | $N/A | Discretionary |
| Nov 25, 2020 | ARNA | $72.0K | Payment | 1,099 | $65.50 | Discretionary |
| Jul 15, 2020 | ARNA | $884.0K | Sale | 13,000 | $68.00 | Discretionary |
| Jul 15, 2020 | ARNA | $341.6K | Option Exercise | 13,000 | $26.28 | Discretionary |